Functional Mesoporous Silica Nanoparticles with a Core-Shell Structure for Controllable Drug Delivery - Advanced Bioactive Inorganic Materials for Bone Regeneration and Drug Delivery - page 80

Ruíz-Hernández E., Lopez-Noriega A., Arcos D., et al. 2007. Aerosol-assisted synthe-
sis of magnetic mesoporous silica spheres for drug targeting. Chem. Mater. 19:
3455-3463.
Selvan S. T., Tan T. T., and Ying J. Y. 2005. Robust, non-cytotoxic, silica-coated CdSe
quantum dots with efficient photoluminescence. Adv. Mater. 17: 1620-1625.
Shi H., He X., Yuan Y., et al. 2010. Nanoparticle-based biocompatible and long-life
marker for lysosome labeling and tracking. Anal. Chem. 82: 2213-2220.
Song Y., Cao X., Guo Y., et al. 2009. Fabrication of mesoporous CdTe/ZnO@SiO 2 core/
shell nanostructures with tunable dual emission and ultrasensitive fluorescence
response to metal ions. Chem. Mater. 21: 68-77.
Stöber W., Fink A., and Bohn E. 1968. Controlled growth of monodisperse silica
spheres in the micron size range. J. Coll. Interf. Sci. 26: 62-69.
Sun J.-T., Hong C.-Y., Pan C.-Y. 2010. Fabrication of PDEAEMA-coated mesoporous
silica nanoparticles and pH-responsive controlled release. J. Phys. Chem. C 114:
12481-12486.
Tan B., and Rankin S. E. 2005. Dual latex/surfactant templating of hollow spherical
silica particles with ordered mesoporous shells. Langmuir 21: 8180-8187.
Tan H., Xue J. M., Shuter B., et al. 2010. Synthesis of PEOlated Fe3O4@SiO2 nanopar-
ticles via bioinspired silification for magnetic resonance imaging. Adv. Funct.
Mater. 20: 722-731.
Tang F. Q., Li L. L., and Chen D. 2012. Mesoporous silica nanoparticles: Synthesis,
biocompatibility and drug delivery. Adv. Mater. 24: 1504-1534.
Tasciotti E., Plant K., Bhavane R., et al. 2008. Mesoporous silicon particles as a
multistage delivery system for imaging and therapeutic applications. Nat.
Nanotechnol. 3: 151-157.
Uboldi C., Giudetti G., Broggi F., et al. 2012. Amorphous silica nanoparticles do not
induce cytotoxicity, cell transformation or genotoxicity in Balb.3T3 mouse fibro-
blasts. Mutation Res. 745: 11-20.
Vallet-Regí M., Balas F., Colilla M., et al. 2008. Bone-regenerative bioceramic implants
with drug and protein controlled delivery capability. Prog. Solid State Chem . 36:
63-191.
Vallet-Regí M., Rámila A., del Real R. P., et al. 2001. A new property of MCM-41: Drug
delivery system. Chem. Mater. 13: 308-311.
Van Speybroeck M., Barillaro V., Thi T. D., et al. 2009. Ordered mesoporous silica
material SBA-15: A broad-spectrum formulation platform for poorly soluble
drugs. J. Pharm. Sci. 98: 2648-2658.
Vivero-Escoto J. L., Slowing I. I., Trewyn B. G., et al. 2010. Mesoporous silica nanopar-
ticles for intracellular controlled drug delivery. Small 6: 1952-1967.
Vivero-Escoto J. L., Slowing I. I., Wu C.-W., et al. 2009. Photoinduced intracellular
controlled release drug delivery in human cells by gold-capped mesoporous
silica nanosphere. J. Am. Chem. Soc. 131: 3462-3463.
Wang F., Tan W. B., Zhang Y., et al. 2006. Luminescent nanomaterials for biological
labelling. Nanotechnology 17: R1.
Wang L. Z., Lei J. Y., Zhang J. L. 2009. Building of multifluorescent mesoporous silica
nanoparticles. Chem. Commun. 16: 2195-2197.
Wu H., Liu G., Zhang S., et al. 2011. Biocompatibility, MR imaging and targeted drug
delivery of a rattle-type magnetic mesoporous silica nanosphere system conju-
gated with PEG and cancer-cell-specific ligands. J. Mater. Chem. 21: 3037-3045.